125 related articles for article (PubMed ID: 2226789)
1. The functional properties of full length and mutant chicken gizzard smooth muscle caldesmon expressed in Escherichia coli.
Redwood CS; Marston SB; Bryan J; Cross RA; Kendrick-Jones J
FEBS Lett; 1990 Sep; 270(1-2):53-6. PubMed ID: 2226789
[TBL] [Abstract][Full Text] [Related]
2. Binding and regulatory properties of expressed functional domains of chicken gizzard smooth muscle caldesmon.
Redwood CS; Marston SB
J Biol Chem; 1993 May; 268(15):10969-76. PubMed ID: 8496161
[TBL] [Abstract][Full Text] [Related]
3. Vascular smooth muscle caldesmon.
Clark T; Ngai PK; Sutherland C; Gröschel-Stewart U; Walsh MP
J Biol Chem; 1986 Jun; 261(17):8028-35. PubMed ID: 2940249
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory complex of smooth muscle caldesmon with actin and tropomyosin involves three interacting segments of the C-terminal domain 4.
Fraser ID; Copeland O; Bing W; Marston SB
Biochemistry; 1997 May; 36(18):5483-92. PubMed ID: 9154931
[TBL] [Abstract][Full Text] [Related]
5. Location of smooth-muscle myosin and tropomyosin binding sites in the C-terminal 288 residues of human caldesmon.
Huber PA; Fraser ID; Marston SB
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):617-25. PubMed ID: 8526878
[TBL] [Abstract][Full Text] [Related]
6. Expression of smooth muscle and nonmuscle tropomyosins in Escherichia coli and characterization of bacterially produced tropomyosins.
Novy RE; Liu LF; Lin CS; Helfman DM; Lin JJ
Biochim Biophys Acta; 1993 Mar; 1162(3):255-65. PubMed ID: 8457589
[TBL] [Abstract][Full Text] [Related]
7. Interaction between chicken gizzard caldesmon and tropomyosin.
Fujii T; Ozawa J; Ogoma Y; Kondo Y
J Biochem; 1988 Nov; 104(5):734-7. PubMed ID: 3235448
[TBL] [Abstract][Full Text] [Related]
8. The functional effects of mutations Thr673-->Asp and Ser702-->Asp at the Pro-directed kinase phosphorylation sites in the C-terminus of chicken gizzard caldesmon.
Redwood CS; Marston SB; Gusev NB
FEBS Lett; 1993 Jul; 327(1):85-9. PubMed ID: 8392947
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the functional domains on the C-terminal region of caldesmon using full-length and mutant caldesmon molecules.
Wang Z; Horiuchi KY; Chacko S
J Biol Chem; 1996 Jan; 271(4):2234-42. PubMed ID: 8567684
[TBL] [Abstract][Full Text] [Related]
10. Characterization of chicken gizzard calcyclin and examination of its interaction with caldesmon.
Filipek A; Zasada A; Wojda U; Makuch R; Dabrowska R
Comp Biochem Physiol B Biochem Mol Biol; 1996 Apr; 113(4):745-52. PubMed ID: 8925441
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Ca2+-dependent effects of caldesmon-tropomyosin-calmodulin and troponin-tropomyosin complexes on the structure of F-actin in ghost fibers and its interaction with myosin heads.
Dobrowolski Z; Borovikov YS; Nowak E; Gałazkiewicz B; Dabrowska R
Biochim Biophys Acta; 1988 Sep; 956(2):140-50. PubMed ID: 3167066
[TBL] [Abstract][Full Text] [Related]
12. Mechanism for the inhibition of acto-heavy meromyosin ATPase by the actin/calmodulin binding domain of caldesmon.
Horiuchi KY; Samuel M; Chacko S
Biochemistry; 1991 Jan; 30(3):712-7. PubMed ID: 1824822
[TBL] [Abstract][Full Text] [Related]
13. Caldesmon, calmodulin and tropomyosin interactions.
Watson MH; Kuhn AE; Mak AS
Biochim Biophys Acta; 1990 Aug; 1054(1):103-13. PubMed ID: 2383599
[TBL] [Abstract][Full Text] [Related]
14. Caldesmon inhibits the cooperative turning-on of the smooth muscle heavy meromyosin by tropomyosin-actin.
Horiuchi KY; Chacko S
Biochemistry; 1989 Nov; 28(23):9111-6. PubMed ID: 2532547
[TBL] [Abstract][Full Text] [Related]
15. Overexpression, purification, and characterization of full-length and mutant caldesmons using a baculovirus expression system.
Wang Z; Horiuchi KY; Jacob SS; Gopalakurup S; Chacko S
J Muscle Res Cell Motil; 1994 Dec; 15(6):646-58. PubMed ID: 7706421
[TBL] [Abstract][Full Text] [Related]
16. In vitro movement of actin filaments on gizzard smooth muscle myosin: requirement of phosphorylation of myosin light chain and effects of tropomyosin and caldesmon.
Okagaki T; Higashi-Fujime S; Ishikawa R; Takano-Ohmuro H; Kohama K
J Biochem; 1991 Jun; 109(6):858-66. PubMed ID: 1939006
[TBL] [Abstract][Full Text] [Related]
17. Caldesmon-binding sites on tropomyosin.
Watson MH; Kuhn AE; Novy RE; Lin JJ; Mak AS
J Biol Chem; 1990 Nov; 265(31):18860-6. PubMed ID: 2229046
[TBL] [Abstract][Full Text] [Related]
18. Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity.
Wang Z; Jiang H; Yang ZQ; Chacko S
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11899-904. PubMed ID: 9342334
[TBL] [Abstract][Full Text] [Related]
19. The effects of phosphorylation of smooth-muscle caldesmon.
Ngai PK; Walsh MP
Biochem J; 1987 Jun; 244(2):417-25. PubMed ID: 2822003
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of the regulatory interaction of the 10 kilodalton C-terminal fragment of caldesmon with actin and the effect of mutation of caldesmon residues 691-696.
Huber PA; Gao Y; Fraser ID; Copeland O; EL-Mezgueldi M; Slatter DA; Keane NE; Marston SB; Levine BA
Biochemistry; 1998 Feb; 37(8):2314-26. PubMed ID: 9485378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
